Anavex Life Sciences Corp (AVXL)

[nidan7500]

Any speculation as to why he would do this? Doesn’t this delay the completed enrollment?

My speculation is he is using the additional trials to generate/gather more data about trial variables. If we say trials do two things. Trials are used to demonstrate efficacy/safety/physio-bio facts about patient well being. The specifics on how success will be measured are written ahead of time and watched as the determination of predicted pass/fail conditions/criteria.

What if, in addition to standard practice as above, he is getting facts about facts on how to really run useful trials? What if he knew exactly what a bio/chem solution looked like and could measure it directly instead of waiting for the patient to demonstrate bio-physics efficacy over time? IMO, he is doing some kind of concurrent bio-physics process development and evaluation. If he has closed the gap between biology and physics studies where he can measure and predict exactly what the human body must do when certain changes are expressed. A poor analogy might be, we know that under certain predicted-controlled conditions water will always boil. We control the altitude, atmospheric variable conditions, water purity, etc, etc...it always boils. These tests are about how to conduct-control the trial and to measure variables. He already knows what the patient clinical outcome will/must be and why.